Pacific Biosciences of California, Inc.: gross profit

What this measure means

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Exact concept: us-gaap:GrossProfit. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2009-01-01 to 2025-12-31. The SEC response was captured on 2026-09-20.

Selected filing history

Related financial histories

• Pacific Biosciences of California, Inc.: total assets
• Pacific Biosciences of California, Inc.: total liabilities
• Pacific Biosciences of California, Inc.: stockholders equity
• Pacific Biosciences of California, Inc.: cash and cash equivalents
• Pacific Biosciences of California, Inc.: net income or loss
• Pacific Biosciences of California, Inc.: operating cash flow
• Pacific Biosciences of California, Inc.: capital expenditure payments
• Pacific Biosciences of California, Inc.: revenue
• Pacific Biosciences of California, Inc.: contract revenue excluding tax
• Pacific Biosciences of California, Inc.: financing cash flow
• Pacific Biosciences of California, Inc.: investing cash flow
• Pacific Biosciences of California, Inc.: retained earnings or deficit
• Pacific Biosciences of California, Inc.: basic weighted-average shares
• Pacific Biosciences of California, Inc.: diluted weighted-average shares
• Pacific Biosciences of California, Inc.: basic earnings per share
• Pacific Biosciences of California, Inc.: diluted earnings per share
• Pacific Biosciences of California, Inc.: income tax expense or benefit
• Pacific Biosciences of California, Inc.: net property, plant and equipment
• Pacific Biosciences of California, Inc.: share-based compensation expense
• Pacific Biosciences of California, Inc.: operating income or loss
• Pacific Biosciences of California, Inc.: current assets
• Pacific Biosciences of California, Inc.: interest expense
• Pacific Biosciences of California, Inc.: current liabilities
• Pacific Biosciences of California, Inc.: current accounts payable
• Pacific Biosciences of California, Inc.: goodwill carrying amount
• Pacific Biosciences of California, Inc.: net finite-lived intangible assets
• Pacific Biosciences of California, Inc.: net current accounts receivable
• Pacific Biosciences of California, Inc.: operating expenses
• Pacific Biosciences of California, Inc.: net inventory
• Pacific Biosciences of California, Inc.: cost of revenue
• Pacific Biosciences of California, Inc.: selling, general and administrative expense
• Pacific Biosciences of California, Inc.: research and development expense

Inspect the source

Entity

Pacific Biosciences of California, Inc. / CIK 0001299130

Captured

2026-09-20T07:50:37.359Z

SEC response SHA-256

7b172fa3ecdfe14ed783ae308e1ecf060ed1c8d9877d8ba12301ef372f8f695e

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001299130.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))